Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

3 Meme Stocks to Sell Before They Do Your Portfolio In

By Joel Baglole, InvestorPlace Contributor
Social media sites, notably WallStreetBets, continue to be filled with chatter about stocks that are heavily shorted by professional traders and could be squeezed and their share price pushed up to unsustainable and unjustified levels.

Best Under-the-Radar Stocks: 3 That AI Predicts Will Soar in July

By Omor Ibne Ehsan
Bard outperformed other AI models and even beat a human reporter in stock picking. It believes these under-the-radar stocks will soar in July.

3 S&P 500 Stocks to Own for the Next 50 Years

By Will Ashworth, InvestorPlace Contributor
These three S&P 500 companies all buy and hold stocks for the next 50 years or more because they operate in attractive industries.

3 Robotics Stocks to Make Your ‘Get Rich’ Dreams Come True

By Faizan Farooque, InvestorPlace Contributor
Explore the world of robotics and seize the opportunity to get rich with strategic investments in this cutting-edge industry.

3 Long-Term Stocks to Make Your ‘Get Rich’ Dreams Come True

By Charles Munyi, InvestorPlace Contributor
Buy these bargain long-term investment stocks that will continue their strong record of revenue growth powered by secular trends.

The 3 Most Undervalued Dividend Aristocrats to Buy Now: July 2023

By Rich Duprey, InvestorPlace Contributor
Dividend investing is a success strategy that juices your portfolio returns when you buy stocks with a long history of raising their payout.

7 F-Rated Stocks to Sell for the Second Half of 2023

By Louis Navellier and the InvestorPlace Research Staff
If your portfolio has any of these F-rated stocks to sell, you should make a move before the second half of 2023 begins.

5 Sizzling Stocks That Are Outperformers in the Market This Year

By Faizan Farooque, InvestorPlace Contributor
Looking for the top performing stocks and market outperformers? Discover the hot stocks to buy and maximize your investment potential.

Why Is Baudax Bio (BXRX) Stock Up 130% Today?

By Josh Enomoto, InvestorPlace Contributor
Although Baudax Bio soared on Friday following its acquisition of Teralmmune, BXRX stock remains an extremely speculative venture.

The 3 Most Undervalued Pharma Stocks to Buy Now: June 2023

By Joel Baglole, InvestorPlace Contributor
Investors looking to buy low and eventually sell high would be smart to take a position with one or more of these pharma stocks.

Why Is Unicycive Therapeutics (UNCY) Down 24% Today?

By William White, InvestorPlace Writer
Unicycive Therapeutics (UNCY) stock is falling on Friday after the medical company provided investors with an update from regulators.

Why Is Renalytix (RNLX) Stock Up 45% Today?

By William White, InvestorPlace Writer
Renalytix (RNLX) stock is rising higher on Friday after the medical company got marketing permission from the FDA for a kidney test.

3 Dividend Stocks That Have Insiders Running for the Exit

By Chris Markoch, InvestorPlace Contributor
One measurement used to find dividend stocks to avoid is the level of insider selling; here are three stocks that fit that description

The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023

By Ian Cooper, InvestorPlace Contributor
If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead.

3 Massively Undervalued Large-Cap Stocks to Buy Now

By Charles Munyi, InvestorPlace Contributor
Add these three undervalued large-cap stocks to buy to your portfolio for huge gains before the market realizes their quality.

Why Is Cormedix (CRMD) Stock Down 23% Today?

By William White, InvestorPlace Writer
Cormedix (CRMD) stock is falling hard on Thursday with heavy trading after the company priced a public offering of its shares.

Why Is BioXcel Therapeutics (BTAI) Stock Down 57% Today?

By William White, InvestorPlace Writer
BioXcel Therapeutics (BTAI) stock is taking a beating on Thursday after the company released its latest clinical trial data.

The 3 Best Psychedelic Stocks to Buy Now

By Alex Sirois, InvestorPlace Contributor
Psychedelic stocks promise to bring therapeutics to market that were taboo until recently and have huge upside.

Why Is Sigilon Therapeutics (SGTX) Stock Up 691% Today?

By William White, InvestorPlace Writer
Sigilon Therapeutics (SGTX) stock is rocketing higher on Thursday morning after Eli Lilly (LLY) agrees to acquire the company.
Load More Articles